InvestorsHub Logo
Followers 200
Posts 9988
Boards Moderated 0
Alias Born 06/14/2006

Re: LittleBird post# 864

Friday, 09/29/2017 12:24:18 PM

Friday, September 29, 2017 12:24:18 PM

Post# of 2676
I'm guessing the analysts are clueless.

Analyst Actions: Piper Jaffray Upgrades Zynerba Pharmaceuticals to Overweight from Neutral

07:08 AM EDT, 09/29/2017 (MT Newswires) -- Zynerba Pharmaceuticals'(ZYNE) average rating among analysts is a hold, with an average price target of $11.

Price: 9.95, Change: +0.51, Percent Change: +5.40

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZYNE News